

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60512</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Impact of Single Nucleotide Polymorphism in the ANKRD55 Gene on Occurrence and Clinical Characteristics of Rheumatoid Arthritis</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Salehi</surname><given-names>Rasoul</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Motaghi</surname><given-names>Mina</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Salehi</surname><given-names>Amirhossein</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Karimzadeh</surname><given-names>Hadi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Pakzad</surname><given-names>Bahram</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>3</issue>
      <fpage>259</fpage>
      <lpage>263</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>7</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2022</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Rheumatoid Arthritis (RA) has multifactorial etiology and numerous genetic and environmental factors have been related to an increased risk of RA. Recently, Genome-Wide Association Studies (GWAS) suggested a large number of Single Nucleotide Polymorphisms (SNPs) loci affecting the susceptibility to RA. One of these loci is rs6859219 (C&amp;gt;A), a functional polymorphism in the &lt;em&gt;ANKRD55&lt;/em&gt; gene which was associated with the expression of &lt;em&gt;ANKRD55&lt;/em&gt; and &lt;em&gt;IL6ST&lt;/em&gt;. In the current study, we evaluated the possible association between rs6859219 (intronic variant) in the &lt;em&gt;ANKRD55&lt;/em&gt; gene with RA risk in the Iranian population.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; A case-control study using 118 RA patients and 115 healthy counterparts was undertaken in order to determine rs6859219 genotypes using real&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;‑&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;time polymerase chain reaction High&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;‑&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Resolution Melting (HRM) method. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; There was a significant difference in the genotype and allele frequencies of rs6859219 between patients and controls (p&amp;lt;0.001). Logistic regression analysis demonstrates that CC genotype and C allele increased the risk of RA (OR &lt;sub&gt;for CC genotype&lt;/sub&gt;= 7.12; 95%CI [3.51-15.05]/ OR &lt;sub&gt;for C allele&lt;/sub&gt;=4.16; 95%CI [2.78-6.28]). Furthermore, regarding the dominant and recessive model of inheritance, RA patients indicated obvious association of the rs6859219 variant compared to healthy controls (p&amp;lt;0.001). Moreover, in the patient group, there was a significant correlation between &lt;span style=&quot;background-color:white&quot;&gt;C-Reactive Protein (CRP) &lt;/span&gt;concentration with rs6859219 polymorphism (p&amp;lt;0.001).&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Our findings propose a substantial correlation between rs6859219 polymorphism and RA risk and clinical characteristics of this disease in the Iranian population.&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
